Cleared Traditional

K053327 - OXICOM CONTROL

K053327 is an FDA 510(k) clearance for OXICOM CONTROL, manufactured by Bionostics, Inc.. The device is a Class 1 Chemistry device with product code JJX cleared through the Traditional 510(k) pathway after a 56-day FDA review.

K053327 · Bionostics, Inc. · Chemistry device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jan 2006
Decision
56d
Days
Class 1
Risk

K053327 is an FDA 510(k) clearance for the OXICOM CONTROL. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Bionostics, Inc. (Devens, US). The FDA issued a Cleared decision on January 26, 2006 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K053327

510(k) Number K053327 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 01, 2005
Decision Date January 26, 2006
Days to Decision 56 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 88d · This submission: 56d
Pathway characteristics
Predicate-based equivalence.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 483
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K053327.
LIBERTY GLUCOSE NORMAL CONTROL SOLUTIONS, MODEL 2120041
K060426 · Liberty Healthcare Group, Inc. · Mar 2006
LIBERTY GLUCOSE CONTROL SOLUTION
K060481 · Liberty Healthcare Group, Inc. · Mar 2006
ISCHEMIA ALBUMIN COBALT BINDING TEST (ACB) ASSAY VERIFICATION SET
K060133 · Inverness Medical Innovations, Inc. · Feb 2006
ARCHITECT DHEA-S CALIBRATORS (A-F) AND CONTROLS (LOW, MEDIUM AND HIGH)
K060027 · Biokit, S.A. · Jan 2006
LIBERTY GLUCOSE CONTROL, MODEL 2120031
K052980 · Liberty Healthcare Group, Inc. · Nov 2005
ROCHE DIAGNOSTICS ELECSYS PROLACTIN II CALCHECK
K053059 · Roche Diagnostics · Nov 2005
K053327 · OXICOM CONTROL
Download PDF FDA Summary Bionostics, Inc.